Investor Relations

Message Board for Partners & Investors

News and updates from Auxesis Pharma for the Investor Hub exclusively.

Documentation available for download.

Finansiell information

Nyheter och uppdateringar från Auxesis Pharma.

Shareholders Register/Aktiebok

The management of our shareholders’ list is now handled by Euroclear. Euroclear will be responsible for maintaining accurate records of our shareholders’ details, including their names, contact information, and shareholding information. They will ensure that all changes and updates are promptly and accurately reflected in the shareholders’ list.


Hanteringen av vår aktieägarlista sköts nu av Euroclear. Euroclear kommer att ansvara för att upprätthålla korrekta register över våra aktieägares uppgifter, inklusive deras namn, kontaktinformation och aktieägarinformation.
De kommer att se till att alla ändringar och uppdateringar snabbt och korrekt återspeglas i aktieägarlistan.


AUXESIS PHARMA HOLDING AB (publ) is now a settlement company and started with Euroclear Sweden AB as the securities institution.

Invitation to the Annual Meeting

The shareholders of AUXESIS PHARMA HOLDING AB (publ) with organization number 559195-6486 are hereby invited to the annual general meeting on June 16, 2023 at 15.00 at Ramberg Law at Jakobsbergsgatan 13 in Stockholm Sweden.

Important Shareholder Information

Document for download regarding registration of sharholders deposit information.

Valuation AUXESIS March 2023

Scenario valuation of the shares in AUXESIS PHARMA HOLDING AB (publ) prior to the launch of the company’s analgesic product ASA.P® is now available.


March 2023 update from the Board

Notice of meeting to the annual General Meeting

One-Pager Scenario Valuation 2022-04-29